Previous studies have reported decreasing hepatitis C virus (HCV) infection rates in the general population. However, differential susceptibility in institutionalized populations suggest that HCV infection is even more prevalent in prison populations than previously reported yet, routine screening for HCV infection among prisoners is not generally available. We estimated the HCV prevalence and identified associated exposures at two maximum-security prisons using data obtained from 2788 inmates from the Risk Factors for Spread of Staphylococcus aureus in Prisons Study in New York, which recruited participants from January 2009 and January 2013. HCV prevalence was 10.1% (n = 295); injection drug use, injection drug use sex partners, and HIV diagnosis exhibited the strongest associations with HCV infection in multivariable models, adjusting for covariates. Taken together, the findings of the present study provide an updated estimate of HCV prevalence and suggest that incarcerated populations represent a declining yet significant portion of the hepatitis epidemic.
Introduction
In comparison with the general population, individuals in correctional systems bear a disproportionately greater burden of infectious disease, including hepatitis C virus (HCV) [1] [2] [3] [4] . The prevalence of HCV infection among incarcerated populations has been reported to range from 9.6% to 41% compared with 1% to 2% in the general U.S. population [2, [4] [5] [6] [7] [8] [9] . The U.S. established a national reporting system for conducting surveillance on viral hepatitis to direct prevention efforts and to control and evaluate the effect of these activities [10] . Unfortunately, this system is highly fragmented and poorly developed, with particular regard to HCV, providing inaccurate estimates of the current burden of the disease [10, 11] . Moreover, the scope of the hepatitis epidemic is poorly understood because the majority of published data are based on national household surveys (e.g., NHANES), which exclude institutionalized populations, including those who are incarcerated [6] .
HCV is a viral disease that results in inflammation of the liver and is linked to a variety of adverse health outcomes, including cirrhosis and hepatocellular cancer [10] . It is the most common chronic bloodborne infection in the U.S., and as there is no effective vaccine or post-exposure prophylaxis, prevention activities to reduce the risk of infection are crucial [12] . In 2013, the reported median cost of treatment varied widely, depending on the severity of HCV infection and therapy recommendation, and ranged between $83,509 and $188,859 per patient; hospitalization and in-patient costs increased this burden twofold, with approximately 24% of diagnosed HCV patients requiring hospital care [13] [14] [15] . Thus, understanding the risk factors that contribute to HCV infection, particularly among high-risk populations, may improve our understanding of the progression of HCV-related chronic conditions and facilitate early interventions aimed at reducing these health risks and costs.
Previous studies have reported decreasing HCV infection rates in the general population. However, differential susceptibility in institutionalized populations suggest that HCV infection is even more prevalent in prison populations than previously reported, yet routine screening for HCV infection among prisoners is not generally available [7, 16, 17] . Although the risk factors for HCV infection have been studied extensively in the general population and the associations are well established, studies have not consistently estimated the prevalence or identified risk factors among incarcerated populations [16] . The purposes of this study are: (1) to estimate the prevalence of HCV infection among inmates entering and in two New York State prisons and (2) to identify predictors of HCV infection risk.
Materials and methods

Sample and setting
Data for this analysis were obtained as part of a 5-year NIH-funded project (Risk Factors for Spread of Staphylococcus aureus in Prisons, 5R01AI082536). Detailed information on the study methodology and sampling has been previously described [18, 19] 
Data collection
Five trained researchers conducted interviews via a structured questionnaire to collect demographic and behavioral information. In addition, inmate medical charts were reviewed and medical data were abstracted. Behavioral information included the duration and frequency of the following: smoking, injection drug use (IDU), tattooing, and body piercing. HCV infection, chronic conditions, and sexual behavior information as well as the diagnostic tests conducted on admission were obtained from the medical chart. Because HCV infection status was abstracted from the medical chart of the prisoner, the diagnosis was not confirmed. Prisoners in the study facilities were only screened for HCV upon admission if they presented with abnormal liver function tests or if their risk profile suggested high-risk behavior. Thus, it is likely that prisoners may misreport HCV status; however, those with HCV infection most likely have the disease.
Statistical analysis
Prevalence of HCV infection as well as inmate demographic and exposure characteristics were 
Results
In this analysis, 2788 inmates were included (1518 males; 1409 females). A total of 295 HCV infections were documented in this study population, with an overall prevalence of 10.1%. Participant characteristics are reported in 
3%). The results from the interaction analysis indicated that HCV prevalence and its associated risks did not vary by gender (results not shown).
The results from the multivariable models, adjusted for age, assessing HCV infection and demographic and behavioral risk factors are reported in Table 2 . The prevalence of HCV infection was significantly elevated among inmates who reported any IDU (adjusted prevalence OR = 64.8; 95% CI = 37.4, 112.1), sex partners who were IDUs (adjusted prevalence OR = 8.0, 95% CI = 3.9, 16.2), and a diagnosis of HIV (adjusted prevalence OR = 4.3; 95% CI = 2.2, 8.3). In addition, the odds of HCV infection was increased twofold among nonHispanic black inmates compared with non-Hispanic white inmates (adjusted prevalence OR = 2.3; 95% CI = 1.4, 3.6) and was increased threefold among those who reported any tattoos and STIs (adjusted prevalence OR = 2.9; 95% CI = 1.9, 4.5 & OR = 3.2; 95% CI = 2.1, 4.9, respectively). Risk behaviors not statistically associated with HCV infection included a history of HBV infection, sexual activity with multiple partners, and piercings.
Discussion
In the present cross-sectional study, we estimated the prevalence of HCV infection and identified risk factors associated with HCV positivity at two maximum-security prisons. The prevalence rate in this population was 10.1%. Inmates with HCV infection were significantly more likely to report a history of IDU, sexual activity with IDUs, and HIV diagnosis. The findings of the present study provide an updated estimate of HCV prevalence and suggest that incarcerated populations represent a declining yet significant portion of the hepatitis epidemic. The high seroprevalence of HCV among inmates is a serious public health concern for several reasons. First, infected individuals may continue to engage in high-risk behaviors and infect others while incarcerated [16] . The results of our study identified additional inmate exposures that may facilitate HCV infection, including tattoos. Tattooing instruments could potentially serve as a transmission vehicle, particularly given the large number of inmates with chronic infections [4, 16] . For example, in one study, prisoners reported knowingly receiving a tattoo with a previously used instrument and/or ink [20] . Despite correctional system prohibitions against tattoos, transmission of HCV infection may still occur as a result of shared instruments. Second, because inmates with HCV infection may not be aware of their infection status and because systematic screening is often not offered in this setting [7, 17] , interventions designed to prevent transmission from close contact cannot be implemented effectively, and subsequent health care services for HCV-infected individuals could prove costly. Third, inmates are often released to the community or transferred to another correctional facility; thus, infected inmates could serve as a reservoir for ongoing HCV transmission [21] .
There are several important limitations to our study. First, HCV status was obtained from medical records. As a result, we do not know how the diagnosis was confirmed because the prisoners in these facilities were screened for HCV upon admission only if they had abnormal liver function tests or if their risk profile upon admission indicated high risk (in the absence of an HCV screen, the inmate might self-report being seropositive and this would be listed as such in the medical record). Thus, in this population, it is likely that some inmates misreport their HCV status; as a result, the prevalence of HCV is likely underestimated. However, those diagnosed with HCV most likely have the disease. Self-reporting a HCV infection, a highly stigmatized condition, has been found to be reliable in numerous epidemiological and intervention studies [22] [23] [24] . For example, in a large multi-site study of young IDUs in metropolitan areas throughout the US, the predictive validity of HCV positivity was estimated at 94% [22] . Thus, given these data to support the predictive validity of HCV positivity and the paucity of information on the risk factors for HCV transmission within US correctional systems, taking advantage of the opportunity provided in this study setting to link epidemiological data to self-reported infection is warranted. It is also likely that exposure to high risk factors (during the risk profile screening) was also misreported; nevertheless, we do not suspect that inmates reported these exposures differentially.
Sustained control and prevention of HCV transmission within correctional systems is urgent, and identification of potential factors associated with HCV risk in this setting provides an important public health opportunity. Screening, diagnosis, and prevention services must be incorporated into correctional health systems to reduce the progression of clinical disease and to stem the transmission of HCV infection.
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